AAP Offers Guidance for Genetic Evaluation of Neurodevelopmental Disorders
By Elana Gotkine HealthDay Reporter
MONDAY, June 30, 2025 -- In a clinical report issued by the American Academy of Pediatrics and published online June 23 in Pediatrics, guidance is provided for the pediatrician regarding the genetic evaluation of developmental delay/intellectual disability.
Lance H. Rodan, M.D., from Boston Children's Hospital, and colleagues note that genetic testing should be selected by phenotype when possible. If medical history, family history, clinical examination, and corollary testing do not lead to a suspected diagnosis, an agnostic or "hypothesis-free" approach is proposed. This approach considers diagnostic yield, test cost and complexity, and potential impact of the results.
A tiered agnostic approach is proposed based on diagnostic yield and practical considerations: Tier 1: genome or exome sequencing and chromosome microarray; Tier 2: Fragile X testing and metabolic testing for inborn errors of metabolism; Tier 3: testing aimed at identifying genetic etiologies that may have been missed in the first two tiers, including consideration of an imprinting disorder, trinucleotide disorders, mitochondrial DNA testing, karyotype evaluation for balanced chromosome rearrangements, and broad screening for intragenic deletions/duplications that may have been missed.
"Genetic neurodevelopmental disorders are common in the pediatric population, and it is vital for the general pediatrician to have an approach for their initial evaluation," the authors write. "Establishing a genetic diagnosis early provides multiple benefits."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Green Space Exposure in Pregnancy, Early Childhood May Cut Risk for Neurodevelopmental Disorders
TUESDAY, July 29, 2025 -- Living near green spaces before and during pregnancy, as well as in early childhood, may lower the risk for neurodevelopmental disorders, according to a...
Air Pollution, Including Ultrafine Particles, Linked to Meningiomas
MONDAY, July 14, 2025 -- Air pollution, including ultrafine particles (UFP), may be associated with developing meningiomas, according to a study published online July 9 in...
Home-Based Exercise, Coaching Improves Fitness in Neuromuscular Diseases
WEDNESDAY, June 4, 2025 -- Combined personalized home-based aerobic exercise and coaching improves physical fitness for people with neuromuscular diseases, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.